ESTRELLA IMMUNOPHARMA, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.6M | $45.6M | $321.7K |
| Jun 2022 | $1.7M | $45.4M | $88.3K |
| Sep 2022 | $2.3M | $45.6M | $73.8K |
| Dec 2022 | $2.7M | $9.7M | $40.8K |
| Mar 2023 | $2.8M | $9.8M | $29.4K |
| Jun 2023 | $9.8M | $3.0M | $2.5M |
| Jul 2023 | — | — | $2.5M |
| Sep 2023 | $17.3M | $27.3M | $22.1M |
| Dec 2023 | $398.7K | $9.4M | $9.0M |
| Mar 2024 | $138.5K | $8.6M | $4.7M |
| Jun 2024 | $180.7K | $4.5M | $4.2M |
| Sep 2024 | $3.0M | $3.7M | $1.8M |
| Dec 2024 | $3.0M | $3.1M | $916.9K |
| Mar 2025 | $4.3M | $2.4M | $421.5K |
| Jun 2025 | $9.1M | $3.0M | $1.3M |
| Sep 2025 | $13.4M | $3.5M | $1.6M |
| Dec 2025 | $13.5M | $3.2M | $1.4M |
| Mar 2026 | $8.9M | $3.7M | $1.9M |
| Jun 2026 | $9.3M | $1.8M | $100.0K |